New DDDs 2020
ATC code | ATC level name | New DDD | ||
---|---|---|---|---|
J05AB03 | vidarabine | 0.7 | g | P |
V03AE10 | sodium zirconium cyclosilicate | 7.5 | g | O |
A10BJ06 | semaglutide | 0.11 | mg | P |
J01AA14 | sarecycline | 0.1 | g | O |
M03BX03 | pridinol | 6 | mg | O |
G03XX01 | prasterone | 6.5 | mg | V |
J05AH03 | peramivir | 0.6 | g | P |
G04BX15 | pentosan polysulfate sodium | 0.3 | g | O |
L04AB07 | opinercept | 7 | mg | P |
J01AA15 | omadacycline | 0.1 | g | P |
J01AA15 | omadacycline | 0.3 | g | O |
A04AD11 | nabilone | 3 | mg | O |
J01MA12 | levofloxacin | 0.24 | g | Inhal.solution |
M04AB05 | lesinurad | 0.2 | g | O |
J05AH04 | laninamivir | 40 | mg | Inhal.powder |
J05AP11 | grazoprevir | 0.1 | g | O |
A16AX09 | glycerol phenylbutyrate | 15 | g | O |
N02CD02 3) | galcanezumab | 4 | mg | P |
N02CD03 | fremanezumab | 7.5 | mg | P |
P01CA03 | fexinidazole | 1.44 | g | O |
J05AX27 | favipiravir | 1.6 | g | O |
N02CD01 2) | erenumab | 2.5 | mg | P |
J04AB06 | enviomycin | 1 | g | P |
J05AP10 | elbasvir | 50 | mg | O |
J05AG06 | doravirine | 0.1 | g | O |
A16AB17 | cerliponase alfa | 21 | mg | P |
J01DD64 | cefpodoxime and beta-lactamase inhibitor | 0.4 1) | g | O |
J04AA03 | calcium aminosalicylate | 15 | g | O |
L04AC12 | brodalumab | 15 | mg | P |
J05AX25 | baloxavir marboxil | 40 | mg | O |
J05AP06 | asunaprevir | 0.2 | g | O |
L02BB05 | apalutamide | 0.24 | g | O |
J05AX26 | amenamevir | 0.4 | g | O |
1) Refers to cefpodoxime
2) Previous ATC code N02CX07, new ATC 4th level N02CD valid from January 2020
3) Previous ATC code N02CX08, new ATC 4th level N02CD valid from January 2020.
2) Previous ATC code N02CX07, new ATC 4th level N02CD valid from January 2020
3) Previous ATC code N02CX08, new ATC 4th level N02CD valid from January 2020.
Last updated: 2019-12-13